Three-dimensional quantitative structure–farnesyltransferase inhibition analysis for some diaminobenzophenones

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Journal of Enzyme Inhibition and Medicinal Chemistry

• Publication date

  2009-11-16

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.3109/14756360902781389PMID 19912055PMCID PMC10725738
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• 3D‐Quantitative Structure–Activity Relationship Studies on Benzothiadiazepine Hydroxamates as Inhibitors of Tumor Necrosis Factor‐α Converting Enzyme

  2008cited by this paper
• Insights into the structural requirements of farnesyltransferase inhibitors as potential anti-tumor agents based on 3D-QSAR CoMFA and CoMSIA models.

  2008cited by this paper
• Exploring three-dimensional quantitative structural activity relationship (3D-QSAR) analysis of SCH 66336 (Sarasar) analogues of farnesyltransferase inhibitors.

  2008cited by this paper
• Malaria Chemotherapeutics. Part 1. History of Antimalarial Drug Development, Currently Used Therapeutics, and Drugs in Clinical Development

  2007cited by this paper
• Malaria Chemotherapeutics Part I: History of Antimalarial Drug Development, Currently Used Therapeutics, and Drugs in Clinical Development

  2007cited by this paper
• Understanding the antitumor activity of novel tricyclicpiperazinyl derivatives as farnesyltransferase inhibitors using CoMFA and CoMSIA.

  2006cited by this paper
• 3D-QSAR analysis of antimalarial farnesyltransferase inhibitors based on a 2,5-diaminobenzophenone scaffold.

  2006cited by this paper
• Thematic review series: Lipid Posttranslational Modifications. Fighting parasitic disease by blocking protein farnesylation Published, JLR Papers in Press, December 7, 2005.

  2006cited by this paper
• Development of farnesyl transferase inhibitors: a review.

  2005cited by this paper
• The global distribution of clinical episodes of Plasmodium falciparum malaria

  2005cited by this paper
• Malaria risk: Estimation of the malaria burden

  2005cited by this paper
• Resistance to a Protein Farnesyltransferase Inhibitor in Plasmodium falciparum*

  2005cited by this paper
• Effectiveness of antimalarial drugs.

  2005cited by this paper
• Recent advances in understanding the antineoplastic mechanisms of farnesyltransferase inhibitors.

  2005cited by this paper
• Protein farnesyltransferase inhibitors exhibit potent antimalarial activity.

  2005cited by this paper
• 2-(aminoacylamino)benzophenones: farnesyltransferase inhibition and antimalarial activity.

  2005cited by this paper
• Non-thiol farnesyltransferase inhibitors: N-(4-aminoacylamino-3-benzoylphenyl)-3-[5-(4-nitrophenyl)-2 furyl]acrylic acid amides and their antimalarial activity.

  2005cited by this paper
• Non-thiol farnesyltransferase inhibitors: N-(4-tolylacetylamino-3-benzoylphenyl)-3-arylfurylacrylic acid amides.

  2004cited by this paper
• 3D QSAR studies on cinnamaldehyde analogues as farnesyl protein transferase inhibitors

  2004cited by this paper
• Structure-based approaches to the development of novel anti-malarials.

  2004cited by this paper
• In vitro and in vivo antimalarial activity of peptidomimetic protein farnesyltransferase inhibitors with improved membrane permeability.

  2004cited by this paper
• 2-(Arylpropionylamino)- and 2-(arylacryloylamino)benzophenones: farnesyltransferase inhibition and antimalarial activity.

  2004influential reference
• Antimalarial drug discovery: efficacy models for compound screening

  2004cited by this paper
• Farnesyltransferase inhibitors inhibit the growth of malaria parasites in vitro and in vivo.

  2004cited by this paper
• New antimalarial drugs.

  2003cited by this paper
• Inhibitors of farnesyltransferase: 5-arylacryloylaminobenzophenones show antimalarial activity.

  2003cited by this paper
• Inhibitors of farnesyltransferase and geranylgeranyltransferase-I for antitumor therapy: substrate-based design, conformational constraint and biological activity.

  2003cited by this paper
• Antimalarial drug discovery: old and new approaches

  2003cited by this paper
• Non-thiol farnesyltransferase inhibitors: N-(4-acylamino-3-benzoylphenyl)-3-[5-(4-nitrophenyl)-2-furyl]acrylic acid amides.

  2003cited by this paper
• Protein farnesyl and N-myristoyl transferases: piggy-back medicinal chemistry targets for the development of antitrypanosomatid and antimalarial therapeutics.

  2003cited by this paper
• Non-thiol farnesyltransferase inhibitors: utilization of an aryl binding site by 5-arylacryloylaminobenzophenones.

  2002cited by this paper
• Comparative Molecular Field Analysis (CoMFA)

  2002cited by this paper
• Non-thiol farnesyltransferase inhibitors: N-(4-Acylamino-3-benzoylphenyl)-4-nitrocinnamic acid amides.

  2002cited by this paper
• Exploration of novel aryl binding sites of farnesyltransferase using molecular modeling and benzophenone-based farnesyltransferase inhibitors.

  2001cited by this paper
• Farnesyltransferase and geranylgeranyltransferase I inhibitors and cancer therapy: Lessons from mechanism and bench-to-bedside translational studies

  2000cited by this paper
• Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity.

  1994cited by this paper
• Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins.

  1988cited by this paper
• Procedures for Detecting Outlying Observations in Samples

  1969cited by this paper

• Farnesyltransferase inhibitors: a comprehensive review based on quantitative structural analysis.

  2013cites this paper
• Application of the discordant outlier detection and separation system in the geosciences

  2012cites this paper
• QSAR studies on imidazopyridazine derivatives as PfPK7 inhibitors

  2011cites this paper
• Imidazole-containing farnesyltransferase inhibitors: 3D quantitative structure–activity relationships and molecular docking

  2009cites this paper
• Send Orders of Reprints at Reprints@benthamscience.net Quantitative Structure-activity Relationships of Imidazole-containing Farnesyltransferase Inhibitors Using Different Chemometric Methods

  year unknowncites this paper